HealthBeaconMonday, 21 January 2019
ByrneWallace advised HealthBeacon, a Dublin and Boston-based digital health company, in relation to its recent $12 million Series A financing. This brings total funding into the company to date to $15 million. The funding will be used to launch its “Smart Sharps” bin system into the US market and to develop its portfolio of medical adherence tools for high value medications. The Smart Sharps bin system has made it easier for patients using injectable medications to stay on track with their treatment schedule, resulting in improved patient medication adherence and driving patient care.
The Series A round was organised by HealthBeacon and Cantor Fitzgerald and was led by Oyster Capital and Elkstone Partners. The participating investors included Quorndon Capital and Cantor Fitzgerald’s Private Client Group. Previous investors in HealthBeacon include Enterprise Ireland, BVP and a range of angel investors.
The ByrneWallace team who advised on this transaction were Brendan Gavin, Partner and Emmet Connolly, Solicitor from the ByrneWallace Corporate Team. For more information on this transaction and to view HealthBeacon’s press release click here.